310 related articles for article (PubMed ID: 28040716)
21. Global Disparities in Breast Cancer Genetics Testing, Counselling and Management.
Yip CH; Evans DG; Agarwal G; Buccimazza I; Kwong A; Morant R; Prakash I; Song CY; Taib NA; Tausch C; Ung O; Meterissian S
World J Surg; 2019 May; 43(5):1264-1270. PubMed ID: 30610270
[TBL] [Abstract][Full Text] [Related]
22. The Role of Genetic Testing in Patients With Breast Cancer: A Review.
Valencia OM; Samuel SE; Viscusi RK; Riall TS; Neumayer LA; Aziz H
JAMA Surg; 2017 Jun; 152(6):589-594. PubMed ID: 28423155
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.
Dhakal B; Patel S; Girnius S; Bachegowda L; Fraser R; Davila O; Kanate AS; Assal A; Hanbali A; Bashey A; Pawarode A; Freytes CO; Lee C; Vesole D; Cornell RF; Hildebrandt GC; Murthy HS; Lazarus HM; Cerny J; Yared JA; Schriber J; Berdeja J; Stockerl-Goldstein K; Meehan K; Holmberg L; Solh M; Diaz MA; Kharfan-Dabaja MA; Farhadfar N; Bashir Q; Munker R; Olsson RF; Gale RP; Bayer RL; Seo S; Chhabra S; Hashmi S; Badawy SM; Nishihori T; Gonsalves W; Nieto Y; Efebera Y; Kumar S; Shah N; Qazilbash M; Hari P; D'Souza A
Leukemia; 2020 Dec; 34(12):3338-3347. PubMed ID: 32313109
[TBL] [Abstract][Full Text] [Related]
24.
Pilarski R
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31216739
[TBL] [Abstract][Full Text] [Related]
25. SEOM clinical guidelines in hereditary breast and ovarian cancer (2019).
González-Santiago S; Ramón Y Cajal T; Aguirre E; Alés-Martínez JE; Andrés R; Balmaña J; Graña B; Herrero A; Llort G; González-Del-Alba A;
Clin Transl Oncol; 2020 Feb; 22(2):193-200. PubMed ID: 31889241
[TBL] [Abstract][Full Text] [Related]
26. Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.
Manahan ER; Kuerer HM; Sebastian M; Hughes KS; Boughey JC; Euhus DM; Boolbol SK; Taylor WA
Ann Surg Oncol; 2019 Oct; 26(10):3025-3031. PubMed ID: 31342359
[TBL] [Abstract][Full Text] [Related]
27. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Miki Y; Swensen J; Shattuck-Eidens D; Futreal PA; Harshman K; Tavtigian S; Liu Q; Cochran C; Bennett LM; Ding W
Science; 1994 Oct; 266(5182):66-71. PubMed ID: 7545954
[TBL] [Abstract][Full Text] [Related]
28. A Population-Based Study of Genes Previously Implicated in Breast Cancer.
Hu C; Hart SN; Gnanaolivu R; Huang H; Lee KY; Na J; Gao C; Lilyquist J; Yadav S; Boddicker NJ; Samara R; Klebba J; Ambrosone CB; Anton-Culver H; Auer P; Bandera EV; Bernstein L; Bertrand KA; Burnside ES; Carter BD; Eliassen H; Gapstur SM; Gaudet M; Haiman C; Hodge JM; Hunter DJ; Jacobs EJ; John EM; Kooperberg C; Kurian AW; Le Marchand L; Lindstroem S; Lindstrom T; Ma H; Neuhausen S; Newcomb PA; O'Brien KM; Olson JE; Ong IM; Pal T; Palmer JR; Patel AV; Reid S; Rosenberg L; Sandler DP; Scott C; Tamimi R; Taylor JA; Trentham-Dietz A; Vachon CM; Weinberg C; Yao S; Ziogas A; Weitzel JN; Goldgar DE; Domchek SM; Nathanson KL; Kraft P; Polley EC; Couch FJ
N Engl J Med; 2021 Feb; 384(5):440-451. PubMed ID: 33471974
[TBL] [Abstract][Full Text] [Related]
29. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.
Giri VN; Knudsen KE; Kelly WK; Abida W; Andriole GL; Bangma CH; Bekelman JE; Benson MC; Blanco A; Burnett A; Catalona WJ; Cooney KA; Cooperberg M; Crawford DE; Den RB; Dicker AP; Eggener S; Fleshner N; Freedman ML; Hamdy FC; Hoffman-Censits J; Hurwitz MD; Hyatt C; Isaacs WB; Kane CJ; Kantoff P; Karnes RJ; Karsh LI; Klein EA; Lin DW; Loughlin KR; Lu-Yao G; Malkowicz SB; Mann MJ; Mark JR; McCue PA; Miner MM; Morgan T; Moul JW; Myers RE; Nielsen SM; Obeid E; Pavlovich CP; Peiper SC; Penson DF; Petrylak D; Pettaway CA; Pilarski R; Pinto PA; Poage W; Raj GV; Rebbeck TR; Robson ME; Rosenberg MT; Sandler H; Sartor O; Schaeffer E; Schwartz GF; Shahin MS; Shore ND; Shuch B; Soule HR; Tomlins SA; Trabulsi EJ; Uzzo R; Vander Griend DJ; Walsh PC; Weil CJ; Wender R; Gomella LG
J Clin Oncol; 2018 Feb; 36(4):414-424. PubMed ID: 29236593
[TBL] [Abstract][Full Text] [Related]
30. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
; Dorling L; Carvalho S; Allen J; González-Neira A; Luccarini C; Wahlström C; Pooley KA; Parsons MT; Fortuno C; Wang Q; Bolla MK; Dennis J; Keeman R; Alonso MR; Álvarez N; Herraez B; Fernandez V; Núñez-Torres R; Osorio A; Valcich J; Li M; Törngren T; Harrington PA; Baynes C; Conroy DM; Decker B; Fachal L; Mavaddat N; Ahearn T; Aittomäki K; Antonenkova NN; Arnold N; Arveux P; Ausems MGEM; Auvinen P; Becher H; Beckmann MW; Behrens S; Bermisheva M; Białkowska K; Blomqvist C; Bogdanova NV; Bogdanova-Markov N; Bojesen SE; Bonanni B; Børresen-Dale AL; Brauch H; Bremer M; Briceno I; Brüning T; Burwinkel B; Cameron DA; Camp NJ; Campbell A; Carracedo A; Castelao JE; Cessna MH; Chanock SJ; Christiansen H; Collée JM; Cordina-Duverger E; Cornelissen S; Czene K; Dörk T; Ekici AB; Engel C; Eriksson M; Fasching PA; Figueroa J; Flyger H; Försti A; Gabrielson M; Gago-Dominguez M; Georgoulias V; Gil F; Giles GG; Glendon G; Garcia EBG; Alnæs GIG; Guénel P; Hadjisavvas A; Haeberle L; Hahnen E; Hall P; Hamann U; Harkness EF; Hartikainen JM; Hartman M; He W; Heemskerk-Gerritsen BAM; Hillemanns P; Hogervorst FBL; Hollestelle A; Ho WK; Hooning MJ; Howell A; Humphreys K; Idris F; Jakubowska A; Jung A; Kapoor PM; Kerin MJ; Khusnutdinova E; Kim SW; Ko YD; Kosma VM; Kristensen VN; Kyriacou K; Lakeman IMM; Lee JW; Lee MH; Li J; Lindblom A; Lo WY; Loizidou MA; Lophatananon A; Lubiński J; MacInnis RJ; Madsen MJ; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Martinez ME; Maurer T; Mavroudis D; McLean C; Meindl A; Mensenkamp AR; Michailidou K; Miller N; Mohd Taib NA; Muir K; Mulligan AM; Nevanlinna H; Newman WG; Nordestgaard BG; Ng PS; Oosterwijk JC; Park SK; Park-Simon TW; Perez JIA; Peterlongo P; Porteous DJ; Prajzendanc K; Prokofyeva D; Radice P; Rashid MU; Rhenius V; Rookus MA; Rüdiger T; Saloustros E; Sawyer EJ; Schmutzler RK; Schneeweiss A; Schürmann P; Shah M; Sohn C; Southey MC; Surowy H; Suvanto M; Thanasitthichai S; Tomlinson I; Torres D; Truong T; Tzardi M; Valova Y; van Asperen CJ; Van Dam RM; van den Ouweland AMW; van der Kolk LE; van Veen EM; Wendt C; Williams JA; Yang XR; Yoon SY; Zamora MP; Evans DG; de la Hoya M; Simard J; Antoniou AC; Borg Å; Andrulis IL; Chang-Claude J; García-Closas M; Chenevix-Trench G; Milne RL; Pharoah PDP; Schmidt MK; Spurdle AB; Vreeswijk MPG; Benitez J; Dunning AM; Kvist A; Teo SH; Devilee P; Easton DF
N Engl J Med; 2021 Feb; 384(5):428-439. PubMed ID: 33471991
[TBL] [Abstract][Full Text] [Related]
31. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer.
Galsky MD; Balar AV; Black PC; Campbell MT; Dykstra GS; Grivas P; Gupta S; Hoimes CJ; Lopez LP; Meeks JJ; Plimack ER; Rosenberg JE; Shore N; Steinberg GD; Kamat AM
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34266883
[TBL] [Abstract][Full Text] [Related]
32. Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
Bardia A; Hurvitz SA; Tolaney SM; Loirat D; Punie K; Oliveira M; Brufsky A; Sardesai SD; Kalinsky K; Zelnak AB; Weaver R; Traina T; Dalenc F; Aftimos P; Lynce F; Diab S; Cortés J; O'Shaughnessy J; Diéras V; Ferrario C; Schmid P; Carey LA; Gianni L; Piccart MJ; Loibl S; Goldenberg DM; Hong Q; Olivo MS; Itri LM; Rugo HS;
N Engl J Med; 2021 Apr; 384(16):1529-1541. PubMed ID: 33882206
[TBL] [Abstract][Full Text] [Related]
33. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Armstrong DK; Alvarez RD; Bakkum-Gamez JN; Barroilhet L; Behbakht K; Berchuck A; Chen LM; Cristea M; DeRosa M; Eisenhauer EL; Gershenson DM; Gray HJ; Grisham R; Hakam A; Jain A; Karam A; Konecny GE; Leath CA; Liu J; Mahdi H; Martin L; Matei D; McHale M; McLean K; Miller DS; O'Malley DM; Percac-Lima S; Ratner E; Remmenga SW; Vargas R; Werner TL; Zsiros E; Burns JL; Engh AM
J Natl Compr Canc Netw; 2021 Feb; 19(2):191-226. PubMed ID: 33545690
[TBL] [Abstract][Full Text] [Related]
34. A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
Khaki AR; Li A; Diamantopoulos LN; Miller NJ; Carril-Ajuria L; Castellano D; De Kouchkovsky I; Koshkin V; Park J; Alva A; Bilen MA; Stewart T; Santos V; Agarwal N; Jain J; Zakharia Y; Morales-Barrera R; Devitt M; Nelson A; Hoimes CJ; Shreck E; Gartrell BA; Sankin A; Tripathi A; Zakopoulou R; Bamias A; Rodriguez-Vida A; Drakaki A; Liu S; Kumar V; Lythgoe MP; Pinato DJ; Murgic J; Fröbe A; Joshi M; Isaacsson Velho P; Hahn N; Alonso Buznego L; Duran I; Moses M; Barata P; Galsky MD; Sonpavde G; Yu EY; Shankaran V; Lyman GH; Grivas P
Eur Urol Oncol; 2021 Jun; 4(3):464-472. PubMed ID: 33423945
[TBL] [Abstract][Full Text] [Related]
35. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Gradishar WJ; Anderson BO; Abraham J; Aft R; Agnese D; Allison KH; Blair SL; Burstein HJ; Dang C; Elias AD; Giordano SH; Goetz MP; Goldstein LJ; Isakoff SJ; Krishnamurthy J; Lyons J; Marcom PK; Matro J; Mayer IA; Moran MS; Mortimer J; O'Regan RM; Patel SA; Pierce LJ; Rugo HS; Sitapati A; Smith KL; Smith ML; Soliman H; Stringer-Reasor EM; Telli ML; Ward JH; Young JS; Burns JL; Kumar R
J Natl Compr Canc Netw; 2020 Apr; 18(4):452-478. PubMed ID: 32259783
[TBL] [Abstract][Full Text] [Related]
36. Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.
Khaki AR; Li A; Diamantopoulos LN; Bilen MA; Santos V; Esther J; Morales-Barrera R; Devitt M; Nelson A; Hoimes CJ; Shreck E; Assi H; Gartrell BA; Sankin A; Rodriguez-Vida A; Lythgoe M; Pinato DJ; Drakaki A; Joshi M; Isaacsson Velho P; Hahn N; Liu S; Alonso Buznego L; Duran I; Moses M; Jain J; Murgic J; Baratam P; Barata P; Tripathi A; Zakharia Y; Galsky MD; Sonpavde G; Yu EY; Shankaran V; Lyman GH; Grivas P
Cancer; 2020 Mar; 126(6):1208-1216. PubMed ID: 31829450
[TBL] [Abstract][Full Text] [Related]
37. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Mohler JL; Antonarakis ES; Armstrong AJ; D'Amico AV; Davis BJ; Dorff T; Eastham JA; Enke CA; Farrington TA; Higano CS; Horwitz EM; Hurwitz M; Ippolito JE; Kane CJ; Kuettel MR; Lang JM; McKenney J; Netto G; Penson DF; Plimack ER; Pow-Sang JM; Pugh TJ; Richey S; Roach M; Rosenfeld S; Schaeffer E; Shabsigh A; Small EJ; Spratt DE; Srinivas S; Tward J; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2019 May; 17(5):479-505. PubMed ID: 31085757
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.
Burstein HJ; Lacchetti C; Anderson H; Buchholz TA; Davidson NE; Gelmon KA; Giordano SH; Hudis CA; Solky AJ; Stearns V; Winer EP; Griggs JJ
J Clin Oncol; 2019 Feb; 37(5):423-438. PubMed ID: 30452337
[TBL] [Abstract][Full Text] [Related]
39. NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.
Flaig TW; Spiess PE; Agarwal N; Bangs R; Boorjian SA; Buyyounouski MK; Downs TM; Efstathiou JA; Friedlander T; Greenberg RE; Guru KA; Hahn N; Herr HW; Hoimes C; Inman BA; Jimbo M; Kader AK; Lele SM; Meeks JJ; Michalski J; Montgomery JS; Pagliaro LC; Pal SK; Patterson A; Petrylak DP; Plimack ER; Pohar KS; Porter MP; Preston MA; Sexton WJ; Siefker-Radtke AO; Tward J; Wile G; Johnson-Chilla A; Dwyer MA; Gurski LA
J Natl Compr Canc Netw; 2018 Sep; 16(9):1041-1053. PubMed ID: 30181416
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
